FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

24442311000001108: Doxepin 25mg capsules (Marlborough Pharmaceuticals Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Apr 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
79180101000001111 Doxepin 25mg capsules (Marlborough Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
79180201000001116 Doxepin 25mg capsules (Marlborough Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Doxepin 25mg capsules (Marlborough Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (Marlborough Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (Marlborough Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (Marlborough Pharmaceuticals Ltd) Is a Product containing precisely doxepin (as doxepin hydrochloride) 25 milligram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (Marlborough Pharmaceuticals Ltd) Has active ingredient Doxepin hydrochloride false Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (Marlborough Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral capsule true Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (Marlborough Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (Marlborough Pharmaceuticals Ltd) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (Marlborough Pharmaceuticals Ltd) Has specific active ingredient Doxepin hydrochloride true Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (Marlborough Pharmaceuticals Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (Marlborough Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Doxepin true Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (Marlborough Pharmaceuticals Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (Marlborough Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (Marlborough Pharmaceuticals Ltd) Has basis of strength substance Doxepin true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Doxepin 25mg capsules (Marlborough Pharmaceuticals Ltd) 28 capsule 2 x 14 capsules Has AMP True Doxepin 25mg capsules (Marlborough Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start